Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells directly within the patient's body. Its lead drug product candidate is CUE-101 for the treatment of human papilloma virus (HPV16+)-driven recurrent/metastatic head and neck cancer. The company is also developing CUE-102 targets Wilms' Tumor 1 protein in various cancers; CUE-103, a CUE-100 series drug product candidate; and Neo-STAT and RDI-STAT programs outside of oncology, including CUE-200, CUE-300, and CUE-400 series. It has collaboration agreements with LG Chem, Ltd. for the development of Immuno-STATs focused in the field of oncology; strategic collaboration and option agreement with Ono Pharmaceutical Co., Ltd. to advance CUE-401 for the treatment of autoimmune and inflammatory diseases; and license agreement with Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

Cue Biopharma, Inc.

Cuentas ( ($CUEN) ) has released a notification of late filing. Cuentas, Inc. has filed a Form 12b-25 to notify investors of a delay in submitting ...

Cuentas delays quarterly SEC filing, seeks brief extension

An update from CopperEx Resources Corporation ( ($TSE:CUEX) ) is now available. CopperEx Resources Corp. reported that all resolutions at its Augus...

CopperEx Shareholders Approve AGM Resolutions, Company Plans Minimum 10-for-1 Consolidation

An announcement from Cue Energy Resources Limited ( ($AU:CUE) ) is now available. Cue Energy Resources has reported total 2P reserves of 4.5 millio...

Cue Energy trims reserves, flags impairments amid portfolio reassessment

Cue Energy Resources Limited ( ($AU:CUE) ) has provided an update. Cue Energy Resources reported stronger June-quarter performance, with total prod...

Cue Energy lifts production, cash and launches new drilling under Horizon Oil control

An announcement from Cue Energy Resources Limited ( ($AU:CUE) ) is now available. Echelon Resources has commenced drilling the Palm Valley 14 appra...

Echelon Resources Starts Palm Valley Gas Appraisal Drilling

Cue Energy Resources Limited ( ($AU:CUE) ) just unveiled an announcement. Cue Energy Resources Limited has begun drilling the PV14 appraisal well, ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CUE	$34.20	0.00%	47
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CUE	$34.20	0%	47
3
4
5
6

CUE

Get Cue Biopharma, Inc. Data in Excel

Get Cue Biopharma, Inc. Data in Excel